Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03932214
Other study ID # PHRIP-18-0617
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date December 19, 2019
Est. completion date January 1, 2025

Study information

Verified date May 2023
Source Assistance Publique - Hôpitaux de Paris
Contact Fabien BOUSSELY, senior officer
Phone 01 49 81 42 50
Email fabien.boussely@aphp.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Peripheral venous catheterization is a fundamental part of the management of critically-ill patients, especially for administration of intravenous emergency treatments. In general, it is preferred to central catheterization whenever possible, since it is less invasive, achievable immediately by the nurse, and responsible for fewer complications. Venous access difficulties are frequent in critically-ill patients. Among tools proposed to improve the practice of peripheral catheterization, ultrasound and infrared illumination are the most studied, the latter being simpler. Infrared illumination has never been evaluated in intensive care. However, the delay or failure of peripheral catheterization is highly detrimental in the context of resuscitation as it may delay or impede appropriate management of vital emergencies. Our study will focus on the peripheral venous catheterization of the upper limbs, as these are the reference site for this technique The objective is to evaluate the interest of infrared illumination (AccuVein AV500®) for the primary success (first puncture) of peripheral venous catheterization of the upper limbs in patients with resuscitation at risk of catheterization venous difficult. It is a comparative, superiority, prospective, multicenter, randomized, controlled, open-label, phase III trial. Subjects will be divided into two groups with a 1: 1 ratio. Nurses at participating centers will be trained for the use of the device prior to the start of the study; the use of the device is singularly easy and intuitive.


Recruitment information / eligibility

Status Recruiting
Enrollment 460
Est. completion date January 1, 2025
Est. primary completion date January 1, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age = 18 years; Hospitalization in intensive care; - Need for a peripheral venous catheter; - Risk of difficult peripheral venous catheterization. In practice, this risk will be considered present if it is impossible to palpate and / or visualize the upper end of the target vein and / or if the estimated vein diameter is smaller than 2mm. This definition is derived from the A-DIVA score (Loon FAJ van et al3). - Affiliation to the social security Exclusion Criteria: - Patient who has already been enrolled in the ICARE study during the current hospitalization; - Refusal of patient's participation

Study Design


Related Conditions & MeSH terms


Intervention

Device:
ACCUVEIN
The nurse uses the Accuvein® device to identify the veins before puncture and then proceeds as usual, under illumination of the device.

Locations

Country Name City State
France Henri-Mondor Hospital Créteil Val De Marne

Sponsors (1)

Lead Sponsor Collaborator
Assistance Publique - Hôpitaux de Paris

Country where clinical trial is conducted

France, 

References & Publications (2)

Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb SA, Beale RJ, Vincent JL, Moreno R; Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013 Feb;41(2):580-637. doi: 10.1097/CCM.0b013e31827e83af. — View Citation

Loon FHJV, Puijn LAPM, Houterman S, Bouwman ARA. Development of the A-DIVA Scale: A Clinical Predictive Scale to Identify Difficult Intravenous Access in Adult Patients Based on Clinical Observations. Medicine (Baltimore). 2016 Apr;95(16):e3428. doi: 10.1097/MD.0000000000003428. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Percentage of primary success of peripheral venous catheterization in the upper limbs. success defined as the need of a single puncture for the effective catheterization.
The effective catheterization is confirmed by obtaining venous reflux by declivity of the infusion bag.
Day 1
Secondary Number of punctures required for peripheral venous catheterization. Day 1
Secondary Rate of failure of the procedure, defined by the absence of placement of a peripheral venous catheter before the end of the procedure Day 1
See also
  Status Clinical Trial Phase
Completed NCT04853290 - Patient Experience in Peripheral Venipuncture With and Without Ultrasound N/A
Completed NCT04853264 - Ultrasound Guided Peripheral Catheterization Increases First-attempt Success Rate N/A
Terminated NCT02265380 - A Randomized Controlled Trial to Demonstrate the Safety and Efficacy of the OptiVein IV Catheter In a Pediatric Population N/A
Completed NCT04177745 - Hot and Cold Applications on PVC Insertion N/A
Recruiting NCT06030141 - Investigation of the Effect of Nigella Sativa Oil and Sesame Oil in Preventing Phlebitis N/A
Completed NCT02789046 - DIFFICULT INTRAVENOUS ACCESS IN ADULTS (VENSCORE)
Completed NCT02584530 - Comparing Ultrasound Guided PICC Line Insertion in Neonates With Standard Procedure N/A
Completed NCT05647889 - Pain and Anxiety in Peripheral Venous Catheterization, Jet Lidocaine, Ice Application N/A
Completed NCT05694390 - The Effect of the Use of Sterile Transparent Film Dressing in Newborns N/A
Recruiting NCT06186518 - The Effect of the PÄ°KSEÇ App on Peripheral Intravenous Catheter Insertion on Success, Pain and Emotional Level in Children N/A